Literature DB >> 1086208

Studies on factor VIII activation potential in hemophilia A-plasma and its significance for the comprehension of hemophilia.

A M Mingers.   

Abstract

In a factor VIII exchange test experiment higher factor VIII activities are measurable than would be expected from the single activities of the used plasmas. The same goes for the use of plasmas from carriers of hemophilia A, but not for plasmas from patients with v.W.J.S. (von-Willebrand Jürgens syndrome). In plasmas from hemophilic adults activation obviously proceeds at a slower rate than in plasmas from hemophilic children. The experimental results lead to the hypothesis that factor VIII for its activation needs a specific activator or activator system. This process can be stopped by natural inhibitors. Contrary to existing opinion, the coagulation defect of hemophilia A is not to be sought in an inability to be activated or even in absence of factor VIII, but in a previous step, in its activator. This activator is absent or defective. In patients with v.W.J.S. disease the activator or activator system is intact, but factor VIII is missing.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1086208     DOI: 10.1007/bf00452096

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  11 in total

1.  BLOOD CLOTTING FACTORS IN PREGNANCY: FACTOR 8 CONCENTRATIONS IN NORMAL AND AHF-DEFICIENT WOMEN.

Authors:  C K KASPER; M S HOAG; P M AGGELER; S STONE
Journal:  Obstet Gynecol       Date:  1964-08       Impact factor: 7.661

2.  Comparative studies on coagulation activities in normal plasmas and their mixtures.

Authors:  A M Minger
Journal:  Eur J Pediatr       Date:  1976-10-01       Impact factor: 3.183

3.  Detection of carriers of classic haemophilia.

Authors:  B Bennett; O D Ratnoff
Journal:  Scott Med J       Date:  1973-03       Impact factor: 0.729

4.  Detection of the carrier state for classic hemophilia.

Authors:  B Bennett; O D Ratnoff
Journal:  N Engl J Med       Date:  1973-02-15       Impact factor: 91.245

5.  [Family members with a congenital defect in the prothrombin complex].

Authors:  A M Mingers; J Ströder
Journal:  Arch Kinderheilkd       Date:  1970

6.  [Factor 8 in a female patient with haemophilia A during pregnancy].

Authors:  A M Mingers; E Göltner
Journal:  Arch Gynakol       Date:  1971-10-28

7.  [Enhanced activity of diminished blood clotting factors in inborn blood coagulation defects].

Authors:  A M Mingers; C Mietens; J Ströder
Journal:  Thromb Diath Haemorrh       Date:  1971-06-30

8.  Immunological differentiation of three types of haemophilia and identification of some female carriers.

Authors:  E Bennett; E R Huehns
Journal:  Lancet       Date:  1970-11-07       Impact factor: 79.321

9.  Immunologic studies of antihemophilic factor (AHF, factor VIII). IV. Radioimmunoassay of AHF antigen.

Authors:  L W Hoyer
Journal:  J Lab Clin Med       Date:  1972-12

10.  Immunologic differentiation of classic hemophilia (factor 8 deficiency) and von Willebrand's dissase, with observations on combined deficiencies of antihemophilic factor and proaccelerin (factor V) and on an acquired circulating anticoagulant against antihemophilic factor.

Authors:  T S Zimmerman; O D Ratnoff; A E Powell
Journal:  J Clin Invest       Date:  1971-01       Impact factor: 14.808

View more
  2 in total

1.  Comparative studies on coagulation activities in normal plasmas and their mixtures.

Authors:  A M Minger
Journal:  Eur J Pediatr       Date:  1976-10-01       Impact factor: 3.183

2.  In vitro studies on the way in which the activation of factor VIII is affected in mixtures of plasma with hemophilia A plasma.

Authors:  A M Mingers
Journal:  Eur J Pediatr       Date:  1976-10-01       Impact factor: 3.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.